Your browser doesn't support javascript.
loading
[The influence and clinical significance of proteasome inhibitor on serum bone metabolite markers in patients with myeloma bone disease].
Ma, R J; Yang, S W; Yuan, X L; Jiang, L; Yang, J; Wang, Z; Zhang, Y; Lei, P C; Zhang, L; Shang, B J; Cheng, L N; Zhu, Z M.
Afiliación
  • Ma RJ; Department of Hematology, Henan Provincial People's Hospital; Institute of Hematology, Henan Provincial People's Hospital, Henan Key Laboratory of Stem Cell Differnetiation and Modification, Zhengzhou 450003, China.
  • Yang SW; Department of Hematology, Henan Provincial People's Hospital; Institute of Hematology, Henan Provincial People's Hospital, Henan Key Laboratory of Stem Cell Differnetiation and Modification, Zhengzhou 450003, China.
  • Yuan XL; Department of Hematology, Henan Provincial People's Hospital; Institute of Hematology, Henan Provincial People's Hospital, Henan Key Laboratory of Stem Cell Differnetiation and Modification, Zhengzhou 450003, China.
  • Jiang L; Department of Hematology, Henan Provincial People's Hospital; Institute of Hematology, Henan Provincial People's Hospital, Henan Key Laboratory of Stem Cell Differnetiation and Modification, Zhengzhou 450003, China.
  • Yang J; Department of Hematology, Henan Provincial People's Hospital; Institute of Hematology, Henan Provincial People's Hospital, Henan Key Laboratory of Stem Cell Differnetiation and Modification, Zhengzhou 450003, China.
  • Wang Z; Department of Hematology, Henan Provincial People's Hospital; Institute of Hematology, Henan Provincial People's Hospital, Henan Key Laboratory of Stem Cell Differnetiation and Modification, Zhengzhou 450003, China.
  • Zhang Y; Department of Hematology, Henan Provincial People's Hospital; Institute of Hematology, Henan Provincial People's Hospital, Henan Key Laboratory of Stem Cell Differnetiation and Modification, Zhengzhou 450003, China.
  • Lei PC; Department of Hematology, Henan Provincial People's Hospital; Institute of Hematology, Henan Provincial People's Hospital, Henan Key Laboratory of Stem Cell Differnetiation and Modification, Zhengzhou 450003, China.
  • Zhang L; Department of Hematology, Henan Provincial People's Hospital; Institute of Hematology, Henan Provincial People's Hospital, Henan Key Laboratory of Stem Cell Differnetiation and Modification, Zhengzhou 450003, China.
  • Shang BJ; Department of Hematology, Henan Provincial People's Hospital; Institute of Hematology, Henan Provincial People's Hospital, Henan Key Laboratory of Stem Cell Differnetiation and Modification, Zhengzhou 450003, China.
  • Cheng LN; Department of Hematology, Henan Provincial People's Hospital; Institute of Hematology, Henan Provincial People's Hospital, Henan Key Laboratory of Stem Cell Differnetiation and Modification, Zhengzhou 450003, China.
  • Zhu ZM; Department of Hematology, Henan Provincial People's Hospital; Institute of Hematology, Henan Provincial People's Hospital, Henan Key Laboratory of Stem Cell Differnetiation and Modification, Zhengzhou 450003, China.
Zhonghua Yi Xue Za Zhi ; 100(26): 2032-2035, 2020 Jul 14.
Article en Zh | MEDLINE | ID: mdl-32654448
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Óseas / Mieloma Múltiple Límite: Humans Idioma: Zh Revista: Zhonghua Yi Xue Za Zhi Año: 2020 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Óseas / Mieloma Múltiple Límite: Humans Idioma: Zh Revista: Zhonghua Yi Xue Za Zhi Año: 2020 Tipo del documento: Article País de afiliación: China